Basu et al., 1993 - Google Patents
Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptorBasu et al., 1993
View PDF- Document ID
- 6674515206877085594
- Author
- Basu M
- Hakimi J
- Dharm E
- Kondas J
- Tsien W
- Pilson R
- Lin P
- Gilfillan A
- Haring P
- Braswell E
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
The Fc-region of immunoglobulin E (IgE) comprising C epsilon 2, C epsilon 3, and C epsilon 4 domains is sufficient for binding to the alpha chain of the high affinity IgE-Fc receptor (Fc epsilon RI alpha). In order to identify the smallest Fc fragment capable of binding to the Fc …
- 238000000746 purification 0 title description 9
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Basu et al. | Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor | |
| US10131711B2 (en) | Human CDR-grafted antibody and antibody fragment thereof | |
| RU2769871C2 (en) | Polyvalent modulators of regulatory t-cells | |
| Chitaev et al. | Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell–cell adhesion | |
| Kassner et al. | Interchangeable alpha chain cytoplasmic domains play a positive role in control of cell adhesion mediated by VLA-4, a beta 1 integrin. | |
| EP1612223A2 (en) | Polypeptides with FC binding ability | |
| US6964854B1 (en) | Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis | |
| Lesley et al. | Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6 | |
| Valentin et al. | Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response | |
| US7507412B2 (en) | Glycoprotein VI fusion proteins | |
| AU2002333241A1 (en) | Glycoprotein VI fusion proteins | |
| CN101103044A (en) | Anti-α9 integrin antibodies and uses thereof | |
| Miyake et al. | Identification of collagen and laminin receptor integrins on murine T lymphocytes | |
| Keegan et al. | Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with FcϵRII and FcϵRI | |
| JP2009132715A (en) | New class ii cytokine receptor and use thereof | |
| JPH09502725A (en) | IL8 inhibitor | |
| US5817768A (en) | Monospecific antibodies against a subunit of fibrinogen | |
| Nicola et al. | Neutralizing and nonneutralizing monoclonal antibodies to the human granulocyte-macrophage colony-stimulating factor receptor alpha-chain | |
| US20040092712A1 (en) | Tlr/cd14 binding inhibitor | |
| Nechansky et al. | Inhibition of antigen-induced mediator release from IgE-sensitized cells by a monoclonal anti-FcεRI α-chain receptor antibody: implications for the involvement of the membrane-proximal α-chain region in FcεRI-mediated cell activation | |
| US6403325B1 (en) | Methods and compounds for treating alzheimer's disease | |
| WO2001004159A1 (en) | Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis | |
| AU697387C (en) | Polypeptides with Fc binding ability | |
| Wagner et al. | Expression of a 4‐(hydroxy‐3‐nitro‐phenyl) acetyl (NP) specific equi‐murine IgE antibody that mediates histamine release in vitro and a type I skin reaction in vivo | |
| WO1998024808A9 (en) | INHIBITION OF IgE-MEDIATED ALLERGIES BY A HUMAN IgE-DERIVED OLIGOPEPTIDE |